ArticleJournal of cancer research and clinical oncology2021

Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experience.

Vineel Bhatlapenumarthi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.